nefopam / Generic mfg. 
Welcome,         Profile    Billing    Logout  
 0 Diseases   5 Trials   5 Trials   154 News 


123»
  • ||||||||||  Retrospective data, Review, Journal, Surgery:  Prevention of postoperative nausea and vomiting after orthognathic surgery: a scoping review. (Pubmed Central) -  Apr 1, 2024   
    For the non-pharmacological methods, throat packs are not recommended for routine use because of their poor effect and serious complications. More prospective RCTs are required to confirm whether gastric aspiration can prevent PONV effectively for patients undergoing orthognathic surgery.
  • ||||||||||  nefopam / Generic mfg., tramadol hydrochloride / Generic mfg.
    Journal, Surgery:  Changes in hospital consumption of opioid and non-opioid analgesics after colorectal endometriosis surgery. (Pubmed Central) -  Nov 28, 2023   
    A history of abdominal surgery (OR?=?0.37 (0.16-0.78, p?=?0.011) and having surgery in 2020 rather than in 2019 (OR?=?0.10 (0.04-0.24, p?<?10)) and in 2021 than in 2019 (OR?=?0.08 (0.03-0.20, p?<?10)) were the only variables independently associated with the risk of opioid use. We found that neither clinical characteristics nor intraoperative findings had an impact on opioid consumption in this setting, and that it was possible to rapidly modify in-hospital analgesic consumption modalities by significantly reducing opioid consumption in favor of NSAIDS or nefopam.
  • ||||||||||  nefopam / Generic mfg.
    Biomarker, Journal, IO biomarker:  Expression signature of ten small nuclear RNAs serves as novel biomarker for prognosis prediction of acute myeloid leukemia. (Pubmed Central) -  Oct 29, 2023   
    Furthermore, we screened six compounds (chicago sky blue 6 B, 5230742, clorsulon, nefopam, nicardipine, and streptomycin) that may serve as targeted therapeutic drugs for AML using connectivity maps...Immune infiltration analysis also revealed significant differences in the abundance of multiple immune cells in the bone marrow of the two groups of AML patients groups. In conclusion, our results revealed a novel prognostic expression signature of AML consisting of ten snRNAs, and we conducted a preliminary exploration of its potential biological functions and tumor immunity.
  • ||||||||||  morphine sulphate / Generic mfg., nefopam / Generic mfg., paracetamol / Generic mfg.
    Trial completion:  Nonopioid Analgesics and Cholecystectomy (clinicaltrials.gov) -  May 6, 2023   
    P3,  N=90, Completed, 
    Recruiting --> Completed Recruiting --> Completed
  • ||||||||||  Rituxan (rituximab) / Biogen, Zenyaku Kogyo, Roche
    New P3 trial:  Role of Nefopam in Rituximab Transfusion Reaction (clinicaltrials.gov) -  Dec 13, 2022   
    P3,  N=100, Not yet recruiting, 
  • ||||||||||  Metapain (nefopam/paracetamol) / Aptys Pharma
    Trial completion:  Nefopam/Paracetamol Fixed Dose Combination in Acute Pain After Impacted Third Molar Extraction (clinicaltrials.gov) -  Nov 14, 2022   
    P3,  N=321, Completed, 
    Nefopam reduced the incidence of CRBD and prevented severe events, but limited by the small number of studies for each intervention and heterogeneous patients. Active, not recruiting --> Completed
  • ||||||||||  Metapain (nefopam/paracetamol) / Aptys Pharma
    Enrollment closed:  Nefopam/Paracetamol Fixed Dose Combination in Acute Pain After Impacted Third Molar Extraction (clinicaltrials.gov) -  Oct 13, 2022   
    P3,  N=321, Active, not recruiting, 
    A single, intraoperative infusion of 20 mg of nefopam did not significantly reduce postoperative (24 hours) morphine consumption in patients undergoing anterior cervical spine surgery. Recruiting --> Active, not recruiting
  • ||||||||||  nefopam / Generic mfg.
    Trial completion date, Surgery:  Nefopam for Post Video-Assisted Thoracoscopic Lobectomy (clinicaltrials.gov) -  Sep 26, 2022   
    P4,  N=92, Recruiting, 
    Therefore, it could be a feasible option for multimodal analgesia in these patients. Trial completion date: Oct 2022 --> Mar 2023
  • ||||||||||  Metapain (nefopam/paracetamol) / Aptys Pharma
    Trial completion date, Trial primary completion date:  Nefopam/Paracetamol Fixed Dose Combination in Acute Pain After Impacted Third Molar Extraction (clinicaltrials.gov) -  Jun 1, 2022   
    P3,  N=321, Recruiting, 
    Regulatory actions regarding the oral nefopam prescription authorization and duration of such prescription are needed. Trial completion date: Jul 2022 --> Oct 2022 | Trial primary completion date: May 2022 --> Oct 2022
  • ||||||||||  nefopam / Generic mfg.
    Preclinical, Journal:  Improvement of Pain Management by Nefopam in a Rat Adjuvant-Induced Arthritis Model. (Pubmed Central) -  May 14, 2022   
    Nefopam provided a slight reduction in the level of pain at the arthritis onset without reducing arthritis severity and bone loss in the rat AIA model. However, it should be administrated orally for a shorter period to avoid inflammation reduction in the long run.
  • ||||||||||  nefopam / Generic mfg.
    Trial completion, Trial completion date, Trial primary completion date, Video, Surgery:  Effects of Continuous Infusion of Intravenous Nefopam on Postoperative Pain and Opioid Consumption After VATS (clinicaltrials.gov) -  May 6, 2022   
    P=N/A,  N=90, Completed, 
    However, it should be administrated orally for a shorter period to avoid inflammation reduction in the long run. Trial completion date: May 2021 --> Nov 2021 | Trial primary completion date: Feb 2021 --> Aug 2021 | Not yet recruiting --> Completed
  • ||||||||||  nefopam / Generic mfg.
    Journal:  Thirty years of nefopam abuse in France (Pubmed Central) -  Nov 25, 2021   
    In conclusion, this study suggests that nefopam produces better postoperative analgesia compared with tramadol in females undergoing c-section. In France, the prescription of nefopam outside of its marketing authorization is regrettable, because it contributes to the development of abuse and drug dependence.
  • ||||||||||  nefopam / Generic mfg.
    Clinical, Journal:  Outpatient surgery of the first ray of the foot: post-operative pain monitoring at home. (Pubmed Central) -  Oct 27, 2021   
    Pain management after outpatient first ray surgery using the injectable Nefopam protocol was satisfactory in the majority of cases, with a high degree of patient satisfaction. This protocol is routinely offered to our patients who must undergo first ray surgery.
  • ||||||||||  Metapain (nefopam/paracetamol) / Aptys Pharma
    Trial completion date, Trial primary completion date:  Nefopam/Paracetamol Fixed Dose Combination in Acute Pain After Impacted Third Molar Extraction (clinicaltrials.gov) -  Sep 27, 2021   
    P3,  N=321, Recruiting, 
    This protocol is routinely offered to our patients who must undergo first ray surgery. Trial completion date: Jul 2021 --> Jul 2022 | Trial primary completion date: Jul 2021 --> May 2022